Background/Objectives: Extrinsic phytosterols supplemented to the diet reduce intestinal cholesterol absorption and plasma low-density lipoprotein (LDL)-cholesterol. However, little is known about their effects on cholesterol metabolism when given in native, unpurified form and in amounts achievable in the diet. The objective of this investigation was to test the hypothesis that intrinsic phytosterols present in unmodified foods alter whole-body cholesterol metabolism. Subjects/Methods: In all, 20 out of 24 subjects completed a randomized, crossover feeding trial wherein all meals were provided by a metabolic kitchen. Each subject consumed two diets for 4 weeks each. The diets differed in phytosterol content (phytosterol-poor diet, 126 mg phytosterols/2000 kcal; phytosterol-abundant diet, 449 mg phytosterols/2000 kcal), but were otherwise matched for nutrient content. Cholesterol absorption and excretion were determined by gas chromatography/mass spectrometry after oral administration of stable isotopic tracers. Results: The phytosterol-abundant diet resulted in lower cholesterol absorption (54.2±2.2% (95% confidence interval 50.5%, 57.9%) vs 73.2 ± 1.3% (69.5%, 76.9%), Po0.0001) and 79% higher fecal cholesterol excretion (1322 ± 112 (1083.2, 1483.3) vs 739 ± 97 mg/day (530.1, 930.2), Po0.0001) relative to the phytosterol-poor diet. Plasma lathosterol/cholesterol ratio rose by 82% (from 0.71 ± 0.11 (0.41, 0.96) to 1.29 ± 0.14 mg/mg (0.98, 1.53), Po0.0001). LDL-cholesterol was similar between diets. Conclusions: Intrinsic phytosterols at levels present in a healthy diet are biologically active and have large effects on whole-body cholesterol metabolism not reflected in circulating LDL. More work is needed to assess the effects of phytosterol-mediated fecal cholesterol excretion on coronary heart disease risk in humans.
Introduction
Phytosterols are plant sterols that are structurally similar to cholesterol. It has been several decades since phytosterols were first reported to have lipid-lowering health effects (Peterson, 1951; Pollak, 1953) . Specifically, phytosterols reduce intestinal cholesterol absorption (Normén et al., 2000) and plasma low-density lipoprotein (LDL)-cholesterol (Piironen et al., 2000; Ostlund, 2002) . These actions form the basis for the recommendation by the National Cholesterol Education Program's Adult Treatment Panel III for adults to consume 2 g phytosterols/day to reduce LDL-cholesterol and cardiovascular disease risk (Expert Panel on Detection, 2001 ). Likewise, the American Heart Association's 2006 Diet and Lifestyle Recommendations (Lichtenstein et al., 2006) promote the consumption of phytosterols daily as a therapeutic option among individuals with elevated LDL-cholesterol.
The potential cardiovascular health benefits of phytosterol supplementation have driven interest in enriching foods with phytosterols to reach the recommended 2-g/day dose, which cannot be achieved with natural foods without extrinsic supplementation. Consequently, little is known about the effects of the intake of intrinsic phytosterols present in non-enriched foods (Piironen and Lampi, 2004) . Phytosterols present in corn oil fed to normolipidemic subjects partially accounted for the differences in plasma cholesterol levels when compared with olive oil (Howell et al., 1998) . A vegan diet containing 732-mg phytosterols/ day reduced total and LDL-cholesterol in patients with rheumatoid arthritis when compared with a normal diet with unspecified phytosterol amounts (Agren et al., 2001) . Corn oil purified to remove sterols increased cholesterol absorption when compared with the original corn oil, suggesting that intrinsic phytosterols present in corn oil reduce cholesterol absorption in humans . However, the potential physiological benefits of intrinsic phytosterols, provided entirely from natural foods in amounts achievable in a healthy diet, are not currently known.
Extensive research has consistently shown that phytosterol supplements reduce cholesterol absorption. However, most previous studies have not eliminated or considered the amount of phytosterols present in the background diet, making it difficult to assess the effects of phytosterols at levels typically achievable in the US diet. We hypothesized that phytosterols present in natural food matrices alter cholesterol metabolism when compared with a novel phytosterol-poor diet.
Materials and methods

Subjects
Volunteers were recruited from the greater Baton Rouge area and the study was conducted at the Pennington Biomedical Research Center (PBRC). Inclusion criteria were healthy individuals aged 18-81 years with plasma LDL-cholesterol between 100 and 189 mg per 100 ml, triglycerides less than 250 mg per 100 ml, resting blood pressure lower than 160/95 mm Hg and body mass index between 20 and 35 kg/m 2 . Participants could not have active medical or surgical illnesses and should not have been taking prescription medicines or dietary supplements known to affect lipid metabolism, although oral contraceptives were allowed. Women who were pregnant, breast feeding or perimenopausal were excluded. The study was approved by the PBRC Institutional Review Board. All participants provided written informed consent.
Phytosterol-poor and phytosterol-abundant diets To provide a control condition for investigating the effects of phytosterols, a phytosterol-poor diet was developed . First, high-phytosterol-containing foods, such as vegetable oils, whole wheat and other whole grains, sesame seeds and almonds, were avoided or minimized in the menus. Second, very-low-phytosterol foods (that is, dairy products, poultry, meat, fish, eggs and refined rice) and ingredients (that is, white-rice flour, potato starch and tapioca flour) were incorporated. Third, soybean oil (Bakers & Chefs, Sam's Club, Maplewood, MO, USA) used in the menus was purified to remove most phytosterols (Ostlund et al., 2003) . To test the effects of phytosterols present in natural forms in the diet without using supplements, a phytosterol-abundant diet was also developed. Foods or ingredients naturally high in phytosterols were incorporated into the menu. As current food databases contain limited information on phytosterol content, it was necessary to analyze several individual foods by gas chromatography/ mass spectrometry when designing the menu.
Both phytosterol-poor and naturally phytosterol-abundant diets were developed as a 5-day menu cycle at six energy levels (1000, 1500, 2000, 2500, 3000 and 3500 kcal), which conformed to the macronutrient recommendations of the Dietary Guidelines for Americans (US Department of Health and Human Services and US Department of Agriculture, 2005) . Unit foods of 100 kcal each, which matched the nutrient composition of the diets, were used to achieve the appropriate energy prescription for each subject. The 5-day menu cycle was repeated throughout the 4-week feeding periods. Table 1 shows the nutrient composition of the diets. The phytosterol-poor diet included 5 g of soluble fiber (Benefiber, Novartis Consumer Health, Inc., Parsippany, NJ, USA), 8 g of insoluble fiber (Solka-Floc, International Fiber Corporation, North Tonawanda, NY, USA), 600 mg potassium and 81 mg magnesium per 2000 kcal given as supplements. The soluble fiber was mixed into beverages and incorporated into three recipes. The insoluble fiber was incorporated into eight recipes, including baked goods, salads and casseroles, to match the fiber content of the phytosterol-abundant diet. Composites of each day's meal plan were analyzed for total phytosterol content by gas chromatography/mass spectrometry after both acid and alkaline hydrolysis.
Clinical protocol
All participants received both the phytosterol-poor and the phytosterol-abundant diet in a randomized, crossover design. Each diet was administered for 4 weeks, with up to 1 week between feeding periods. All foods and beverages were prepared in the PBRC Metabolic Kitchen. Participants were allowed a limited choice of additional seasonings and beverages. They were required to consume breakfast and dinner at the feeding center during weekdays, with the rest of the meals taken outside. Participants began on an energy level that most closely matched their energy requirement based on their estimated resting metabolic rate and physical activity level (Harris and Benedict, 1919 ; Food and Agricultural Organization/World Health Organization/United Nations University, 1985). Energy levels were adjusted if body weight changed. Participants were instructed to consume all food and beverages provided. Compliance was determined by weighing any food and beverages that were not consumed, by obtaining daily logs of self-reported intake and by measuring plasma phytosterol concentrations during each diet period.
Outcome measurements
Cholesterol absorption and excretion. Fecal cholesterol excretion and intestinal cholesterol absorption were determined by administering gelatin capsules containing 2 mg 25,26, 26,26,27,27,27-( 2 H 7 )cholesterol (CDN Isotopes, Quebec, Canada) and 1 mg 5,6,22,23-( 2 H 4 )sitostanol (Medical Isotopes, Pelham, NH, USA) dissolved in soybean oil twice daily for the last 5 days of each 28-day feeding period. Stool samples were collected on days 27 and 28, saponified, extracted and analyzed for cholesterol, coprostanol, coprostanone and sitostanol content (Lutjohann et al., 1993) H 4-sitostanol capsule )). Dietary cholesterol excretion was calculated as cholesterol diet À(cholesterol diet Â percent cholesterol absorbed) and endogenous cholesterol excretion as total cholesterol excretedÀdietary cholesterol excreted. Plasma cholestanol and lathosterol were measured as markers for cholesterol absorption and biosynthesis, respectively, and normalized after dividing by the total plasma cholesterol concentration (Miettinen et al., 1989) . Samples were drawn in the morning after a 10-h fast on days 24 and 28 of each feeding period for the determination of total, HDL-, and LDL-cholesterol and triglycerides. Total cholesterol and glycerol-blanked triglycerides were measured by automated enzymatic commercial kits. HDL-cholesterol was measured in serum after precipitation of apolipoprotein Bcontaining lipoproteins by dextran sulfate and magnesium (Warnick et al., 1982) . LDL-cholesterol was calculated using the Friedewald equation (Friedewald et al., 1972) . Results for days 24 and 28 were averaged.
Statistical analyses
Statistical analyses were conducted using SAS (version 9.2, SAS Institute Inc., Cary, NC, USA). Proc Mixed was employed to analyze the fixed effects of phytosterol intake, period and interaction between phytosterol intake and period to assess carryover effects. No significant carryover effects were observed for any of the outcome measures. The statistical power to detect a 5% difference in LDL-cholesterol between the two diets at a significance level of 0.05 assuming a 5% coefficient of variation is 85%.
Results
Phytosterol-poor and phytosterol-abundant diets
The phytosterol-poor and phytosterol-abundant diets contained 126 ± 8 and 449 ± 19 mg of phytosterols per 2000 kcal, respectively (Table 1) . Campesterol, stigmasterol and sitosterol accounted for 16.0±0.4, 14.6±0.8 and 69.4±0.5% of total phytosterols, respectively, for the phytosterol-poor diet; corresponding values for the phytosterol-abundant diet were 17.0±0.6, 9.8±0.2 and 73.2±0.5%. By design, average phytosterol intake during the phytosterol-abundant diet (512 ± 23 mg/day) was 3.6-fold that of the phytosterol-poor diet (140 ± 7 mg/day).
Compliance
In all, 24 subjects (18F, 6M) were randomized. Three subjects dropped out during the first week of the first dietary period and another during the first week of the second dietary period. Twenty subjects (15F, 5M) completed both diet periods and are the subject of this report. Baseline characteristics of the participants are listed in Table 2 . Body weight, blood pressure, pulse and fasting plasma glucose were stable throughout the study.
Only 8 out of 1600 meals (0.5%) that were supposed to be eaten at the feeding center were missed and 6 of these 8 were owing to excused absences. Energy intake during the two feeding periods averaged 2317±17 kcal/day; the prescribed energy intake averaged 2322 ± 17 kcal/day. As expected, total plasma phytosterols normalized to cholesterol increased by 68% during the phytosterol-abundant diet as compared with the phytosterol-poor diet (Po0.0001, Table 3 ). Plasma campesterol (Po0.0001), stigmasterol (Po0.001) and sitosterol (Po0.0001) were significantly higher on the phytosterol-abundant diet (Table 3) .
Whole-body cholesterol metabolism
Percentage cholesterol absorption determined by gas chromatography/mass spectrometry was 26.0% lower with the phytosterol-abundant diet relative to the phytosterol-poor diet (Po0.0001, Table 3 ). As shown in Figure 1a , this effect was consistent across subjects. In agreement with these findings, the ratio of plasma cholestanol to plasma cholesterol (an indicator of fractional cholesterol absorption) was 45% lower (Po0.0001) on the phytosterol-abundant diet. Absolute cholesterol absorption, expressed as mg total cholesterol absorbed/day, was not significantly different during the two diet periods despite large differences in absorption efficiency.
The greatest effects of the phytosterol-abundant diet were on cholesterol excretion. Fecal cholesterol excretion was 79% higher on the abundant diet (Po0.0001, Table 3 and Figure 2 ). Although both dietary and endogenous cholesterol excretion were higher, endogenous cholesterol excretion accounted for most of the differences between diet conditions. The ratio of plasma lathosterol to cholesterol, an indicator of cholesterol biosynthesis, was 82% larger on the phytosterol-abundant diet (Table 3) .
Lipoprotein concentrations
Despite large differences in cholesterol absorption and cholesterol excretion between the two diet periods, LDLcholesterol concentrations were similar (Table 3 and Figure 1b ). Concentrations of total cholesterol, HDL-cholesterol and triglycerides were also stable for both diet periods (Table 3) .
Discussion
We tested the hypothesis that intrinsic phytosterols present in natural food matrices reduce fractional cholesterol absorption and increase fecal cholesterol excretion when consumed in modest amounts achievable in a natural diet. Using specially designed diets that differed only in phytosterol content, we demonstrated that 512 mg/day intrinsic phytosterols alter whole-body cholesterol metabolism when compared with a phytosterol-poor diet. Although most previous studies have used phytosterol supplements of 2 g daily added to an ad libitum diet of uncontrolled phytosterol content, the present work used only naturally occurring phytosterols in a modest dose that was substantially lower than those of supplement studies, and phytosterols in both diets were carefully quantified and controlled.
Our results confirm and extend previous single-meal studies that show that selected food phytosterols delivered in natural matrices are bioactive (Ostlund, 2002; Ostlund et al., 2003; Lin et al., 2009) . The general question of whether food phytosterols are bioactive is important because some forms of the phytosterols (for example, purified phytosterols in crystalline form) appear to have little or no biological activity (Denke, 1995; Ostlund et al., 1999) .
Fractional cholesterol absorption was substantially lower on the phytosterol-abundant diet, an effect that was expected based on phytosterols' mechanism of action. The Natural phytosterols and cholesterol metabolism X Lin et al relatively high percentage of cholesterol absorption (73.2 ± 1.3%) that we observed with the phytosterol-poor diet is higher than the 60% mean reported in the literature (Lutjohann et al., 1993) , which is likely explained by its unusually low phytosterol content. Fecal cholesterol elimination (predominantly endogenous cholesterol) was significantly greater with the phytosterolabundant diet (Figure 2 ). Increased cholesterol excretion was paralleled by increases in cholesterol biosynthesis, indicated by plasma lathosterol, showing that the increased cholesterol excretion was sufficient to generate a strong compensatory response due to relative tissue cholesterol deficiency. The ability of phytosterol supplements to increase plasma lathosterol has been reported previously (Nestel et al., 2001) and our work extends that finding to comparatively lower amounts of phytosterols in foods.
Circulating LDL-cholesterol concentration was not lower on the phytosterol-abundant diet. This is not surprising in light of the following factors. First, the phytosterol intake of 512 mg/day was based on the amount achievable in a natural diet, but was not optimized for lowering LDL-cholesterol. Phytosterol supplement studies show that doses of 2 g/day are needed for optimum reduction of LDL-cholesterol (Demonty et al., 2009) , whereas the US Food and Drug Administration requires products to provide at least 800 mg/day in order to include a health claim on their labels (US Food and Drug Administration, 2008). A recent controlled feeding study comparing 459 and 59 mg/day phytosterols given as phytosterol ester supplements showed a non-significant 5% reduction in LDL-cholesterol. Second, a feeding period longer than 4 weeks may be necessary to observe an effect on LDL-cholesterol concentration. In support of this, a previous trial using 2 g/day of phytosterols showed that LDL-cholesterol concentrations were unchanged after 4 weeks, but were reduced significantly after 8 or 12 weeks (Devaraj et al., 2006) . Third, the compensatory increase in whole-body cholesterol synthesis, as demonstrated by higher plasma lathosterol concentrations, may have prevented a potential reduction in LDL-cholesterol. Thus, a combination of inhibiting cholesterol synthesis and inhibiting cholesterol absorption may be more effective in reducing LDL-cholesterol (Turley and Dietschy, 2003) than either approach alone. Taken together, these data suggest that phytosterols are unlikely to have significant effects on LDLcholesterol after only 4 weeks when consumed at levels much less than 2 g/day.
Our results suggest that phytosterols are bioactive in their natural food matrices and in amounts (around 500 mg/day) that can be readily achieved in the diet without supplementation (Nair et al., 1984; Ostlund 2002; Racette et al., 2009 ). We could not attribute the cholesterol metabolic differences to differences in macronutrients, cholesterol, fat quality, Natural phytosterols and cholesterol metabolism X Lin et al vitamins or minerals. In order to match the fiber contents of the two diets, the phytosterol-poor diet was supplemented with soluble and insoluble fiber by incorporating it into many foods. It is possible that supplemented dietary fiber may differ from that contained in natural food matrices, representing a potential limitation of the study. Although it is possible that the differences observed in fecal cholesterol excretion were due to another unmeasured dietary component, phytosterols are the principal dietary factor known to regulate cholesterol absorption. A similar controlled feeding study using 459 mg purified phytosterols given in phytosterol ester supplements produced reductions in fractional cholesterol absorption (10%) and increases in fecal cholesterol excretion (36%) (Racette et al., 2010) . The somewhat larger reductions in fractional cholesterol absorption (26%) and increases in fecal cholesterol excretion (79%) observed in the present study may be attributable to greater bioavailability of intrinsic food phytosterols as compared with phytosterol supplements, or with other experimental differences between the studies.
The effects of phytosterols on cholesterol absorption are well established, yet comparatively little is known regarding phytosterol's effects on atherosclerosis or clinical outcomes. In apoE À/À mice, disrupting Npc1l1 or treating with ezetimibe decreased cholesterol absorption as well as circulating cholesterol and prevented atherosclerosis (Davis et al., 2007) , suggesting that reducing cholesterol absorption has the potential to favorably affect atherosclerosis. Accumulating evidence, however, supports the notion that interventions that hinder atherosclerosis progression and/ or enhance atherosclerosis regression can act independently of the effects on LDL-cholesterol. Constrictive remodeling of the arterial wall with statin therapy was not associated with changes in LDL-cholesterol, but was linked to anti-inflammatory effects (Schoenhagen et al., 2006) . Similarly, the antiatherosclerotic action of the synthetic LXR agonists (which inhibits the development of atherosclerosis) in apoE À/À and LDL-receptor-deficient mice was independent of changes in plasma lipid profiles (Joseph et al., 2002; Terasaka et al., 2003) . Higher cholesterol absorption but lower cholesterol synthesis (estimated by plasma cholestanol and phytosterols, and lathosterol levels, respectively) was observed in cardiovascular disease cases compared with controls in the Framingham Offspring Study. LDL-cholesterol concentrations were similar and these biomarkers were better predictors of cardiovascular disease than traditional lipid risk factors (Matthan et al., 2009) , suggesting that changes in cholesterol homeostasis without changes in LDL-cholesterol might be related to cardiovascular disease risk. Currently, the phytosterol content of foods is not taken into consideration in prescribed therapeutic diets and is not consistently included in nutrient databases. In fact, designing the phytosterol-poor and phytosterol-abundant diets was a challenge for the investigators due to the paucity of phytosterol data, requiring substantial chemical analysis and recipe experimentation. We suggest that food phytosterols represent a potentially new approach to improve dietary treatment and prevention of coronary heart disease and that this approach requires additional research on two fronts. First, accurate analyses of food phytosterols are critical for the design of dietary trials. Second, the relationship of reverse cholesterol transport and phytosterols with coronary heart disease risk needs further study. Most investigations focus on the pharmaceutical approach of lowering LDL-cholesterol, but it may be advantageous to use an old and well-known nutrient, phytosterols, to test the hypothesis that whole-body cholesterol metabolism is related to heart disease risk independently of circulating LDLcholesterol in humans.
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